These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2880114)

  • 1. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric.
    Montgomery JC; Appleby L; Brincat M; Versi E; Tapp A; Fenwick PB; Studd JW
    Lancet; 1987 Feb; 1(8528):297-9. PubMed ID: 2880114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study.
    Brincat M; Magos A; Studd JW; Cardozo LD; O'Dowd T; Wardle PJ; Cooper D
    Lancet; 1984 Jan; 1(8367):16-8. PubMed ID: 6140343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report.
    Cohen LS; Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL
    Am J Psychiatry; 2003 Aug; 160(8):1519-22. PubMed ID: 12900318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome.
    Magos AL; Brewster E; Singh R; O'Dowd T; Brincat M; Studd JW
    Br J Obstet Gynaecol; 1986 Dec; 93(12):1290-6. PubMed ID: 3801360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hormone implants on psychological disorders in the climacteric.
    Sherwin BB
    Lancet; 1987 May; 1(8540):1038-9. PubMed ID: 2883380
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study.
    Pearce J; Hawton K; Blake F; Barlow D; Rees M; Fagg J; Keenan J
    J Psychosom Res; 1997 Feb; 42(2):177-86. PubMed ID: 9076645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of climacteric complaints with Org OD 14: a comparative study with oestradiol valerate and placebo.
    Crona N; Samsioe G; Lindberg UB; Silfverstolpe G
    Maturitas; 1988 Mar; 9(4):303-8. PubMed ID: 3288845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of Folivirin in the treatment of postclimacteric syndrome (author's transl)].
    Pontuch A; Lipenský S
    Cesk Gynekol; 1974 Sep; 39(8):606-8. PubMed ID: 4434525
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of 25 mg and 50 mg oestradiol implants in the control of climacteric symptoms following hysterectomy and bilateral salpingo-oophorectomy.
    Panay N; Versi E; Savvas M
    BJOG; 2000 Aug; 107(8):1012-6. PubMed ID: 10955434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H; Al-Azzawi F;
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results.
    Burger HG; Hailes J; Menelaus M; Nelson J; Hudson B; Balazs N
    Maturitas; 1984 Dec; 6(4):351-8. PubMed ID: 6442755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: The treatment of climacteric disorders with a combination of estradiol and testosterone--an outline of the pathogenesis of psychic symptoms in the climacterium.
    Navrátil J; Nováková D; Pichner J
    Act Nerv Super (Praha); 1975; 17(4):307-8. PubMed ID: 1221812
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of subcutaneous hormone implants during climacteric.
    Cardozo L; Gibb DM; Tuck SM; Thom MH; Studd JW; Cooper DJ
    Maturitas; 1984 Mar; 5(3):177-84. PubMed ID: 6727691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK; Bunyavejchevin S
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal oestrogen for treatment of severe postnatal depression.
    Gregoire AJ; Kumar R; Everitt B; Henderson AF; Studd JW
    Lancet; 1996 Apr; 347(9006):930-3. PubMed ID: 8598756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of estrogen supplementation on psychological variables in climacteric women].
    Gramegna G; Blümel JE; Jara S; Schiattino I; Lolas F
    Rev Med Chil; 1996 Oct; 124(10):1240-4. PubMed ID: 9239913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms of oestrogen deficiency associated with supraphysiological plasma oestradiol concentrations in women with oestradiol implants.
    Gangar K; Cust M; Whitehead MI
    BMJ; 1989 Sep; 299(6699):601-2. PubMed ID: 2508819
    [No Abstract]   [Full Text] [Related]  

  • 19. Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants.
    Savvas M; Bishop J; Laurent G; Watson N; Studd J
    Br J Obstet Gynaecol; 1993 Feb; 100(2):154-6. PubMed ID: 8476808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of transdermal testosterone and oestrogen therapy on dry eye in postmenopausal women: a randomised, placebo-controlled, pilot study.
    Golebiowski B; Badarudin N; Eden J; Gerrand L; Robinson J; Liu J; Hampel U; You J; Stapleton F
    Br J Ophthalmol; 2017 Jul; 101(7):926-932. PubMed ID: 27811278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.